Newstv99 : Mumbai, May 07, 2026: Pharma major Lupin Limited [BSE: 500257 | NSE: LUPIN] reported its financial performance for the quarter and fiscal year ending March 31, 2026. These audited results were taken on record by the Board of Directors at a meeting held today. Based on the long-term outlook the Board has recommended a dividend of 9
Financial Highlights – Consolidated IND-AS
Amt in INR Mn
Particulars
Full Year
Quarter
FY2026
FY2025
YoY Growth %
Q4 FY2026
Q4 FY2025
YoY Growth %
Q3 FY2026
QoQ Growth %
Sales
2,74,875
221,921
↑23.9%
73,919
55,622
↑ 32.9%
71,005
↑ 4.1%
EBITDA
92,405
54,792
↑68.6%
26,263
13,781
↑ 90.6%
23,766
↑ 10.5%
EBITDA Margin (%)*
33.6%
24.7%
↑ 890 bps
35.5%
24.8%
↑ 1070 bps
33.5%
↑ 200 bps
PBT
68,726
40,150
↑71.2%
19,280
8,958
↑ 115.2%
15,220
↑ 26.7%
PAT
53,555
33,063
↑62.0%
14,687
7,824
↑ 87.7%
11,805
↑ 24.4%
*Includes forex & other income
Income Statement highlights – Q4 FY2026
Gross Profit was up 42.9% at INR 55,403 Mn from INR 38,760 Mn in Q4FY2025, with a gross margin of 75.0%.
Personnel cost was 16.8% of sales at INR 12,427 Mn compared to INR 10,013 Mn in Q4 FY2025.
Manufacturing and other expenses were 29.9% of sales at INR 22,093 Mn compared to INR 16,876 Mn in Q4 FY2025.
PBT at INR 19,280 Mn was 26.1% of sales, up 115.2% YoY from INR 8,958 Mn in Q4 FY2025.
Investment in R&D for the quarter was INR 5,898 Mn (8.0% of sales).
Balance Sheet highlights
Operating working capital was INR 71,324 Mn as on quarter end; Operating days for quarter stood is 87 days
Capital Expenditure for the quarter was INR 3,052 Mn and for the year was INR 10,618 Mn.
Net Debt as on March 31, 2026, stands at INR -46,358 Mn.
Net Debt Equity as on March 31, 2026, stands at -0.21.
Mr. Nilesh Gupta, Managing Director, Lupin Limited said “Our fourth quarter and full-year results underscore the strength and resilience of our business across key geographies, with the U.S. and India delivering strong sales growth and margin expansion. Building on this momentum, we are well-positioned to accelerate performance through strategic investments in technology, disciplined execution, and operational efficiencies, driving sustainable and profitable growth”.
